Key result
The BNT162b2 mRNA COVID-19 vaccine was evaluated for its association with myocardial infarction, stroke, and pulmonary embolism in people aged 75 years or older.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Jabagi et al. (2021) studied this question. The BNT162b2 mRNA COVID-19 vaccine was evaluated for its association with myocardial infarction, stroke, and pulmonary embolism in people aged 75 years or older.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: